Abilify Maintena (aripiprazole extended release)

Abilify Asimtufii (aripiprazole prolonged-release)

Brand name: Abilify Asimtufii®

Active ingredient: Aripiprazole

Type: Atypical antipsychotic

Available from: Otsuka Canada + Lundbeck Canada

Form: Long‑acting injectable (720 mg/2.4 mL and 960 mg/3.2 mL)

Generic: No

Listed on Ontario formulary: No

OHIP+ coverage: No

What is Abilify Asimtufii used for?

Maintenance treatment of schizophrenia and bipolar I disorder in adults.

How should I take Abilify Asimtufii?

A prolonged‑release intramuscular injection, given in the gluteal muscle.
Administered every 2 months (every 56+ days).

Initiation typically includes 14 days of oral therapy overlap.

Common side effects

Same as Abilify, plus:

• Injection‑site pain

Rare but serious side effects

Same as Abilify.

Warnings/Precautions

Same impulse‑control and dementia‑related psychosis warnings as other aripiprazole products.

Medication interactions

Same as Abilify and Abilify Maintena.